Ad is loading...
FNWFX
Price
$80.36
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

FNWFX vs RNWFX

Header iconFNWFX vs RNWFX Comparison
Open Charts FNWFX vs RNWFXBanner chart's image
American Funds New World F3
Price$80.36
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
FNWFX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNWFX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
FNWFX (60.9B) and RNWFX (60.9B) have equal amount of cash in the bank . FNWFX (1.56) and RNWFX (1.51) have matching dividends . FNWFX was incepted earlier than RNWFX: FNWFX (8 years) vs RNWFX (23 years). FNWFX (32.00) and RNWFX (32.00) have comparable annual turnover. RNWFX has a lower initial minimum investment than FNWFX: RNWFX (250) vs FNWFX (1000000). FNWFX (11.59) and RNWFX (11.54) have marching annual gain over last year. FNWFX (17.23) and RNWFX (17.17) have equivalent 5 years return.
FNWFXRNWFXFNWFX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD7.1477.099101%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B60.9B100%
Annual Yield % from dividends1.561.51103%
Returns for 1 year11.5911.54100%
Returns for 3 years-14.49-14.55100%
Returns for 5 years17.2317.17100%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDU55.900.85
+1.54%
New Oriental Education and Technology Group
HTGC18.92-0.13
-0.68%
Hercules Capital
AZ6.49-0.11
-1.67%
A2Z Cust2Mate Solutions Corp
REPL10.80-0.60
-5.26%
Replimune Group
POAI0.69-0.05
-7.23%
Predictive Oncology